| 1 | 17398 | Purification of carboxypeptidase B from human pancreas. | Biochem J | 1977 May 1 |
2 |
| 2 | 6840191 | Systemic apomorphine reverses intrastriatal dopamine-induced contralateral deviation. | Eur J Pharmacol | 1983 Feb 18 |
3 |
| 3 | 7782309 | Purification and characterization of TAFI, a thrombin-activable fibrinolysis inhibitor. | J Biol Chem | 1995 Jun 16 |
1 |
| 4 | 8596159 | Bone mineral density in a native population of Argentina with low calcium intake. | J Rheumatol | 1995 Nov |
1 |
| 5 | 8663147 | TAFI, or plasma procarboxypeptidase B, couples the coagulation and fibrinolytic cascades through the thrombin-thrombomodulin complex. | J Biol Chem | 1996 Jul 12 |
1 |
| 6 | 9045633 | Functional characterization of recombinant human meizothrombin and Meizothrombin(desF1). Thrombomodulin-dependent activation of protein C and thrombin-activatable fibrinolysis inhibitor (TAFI), platelet aggregation, antithrombin-III inhibition. | J Biol Chem | 1997 Mar 7 |
2 |
| 7 | 9153272 | Thrombin-mediated activation of factor XI results in a thrombin-activatable fibrinolysis inhibitor-dependent inhibition of fibrinolysis. | J Clin Invest | 1997 May 15 |
2 |
| 8 | 9162090 | On the mechanism of the antifibrinolytic activity of plasma carboxypeptidase B. | J Biol Chem | 1997 May 30 |
2 |
| 9 | 10220902 | The role of the Sphingomonas species UG30 pentachlorophenol-4-monooxygenase in p-nitrophenol degradation. | FEMS Microbiol Lett | 1999 Apr 1 |
1 |
| 10 | 10227759 | Elevated bradykinin and decreased carboxypeptidase R as a cause of hypotension during tryptophan column immunoabsorption therapy. | Ther Apher | 1998 Nov |
1 |
| 11 | 10351989 | Assay of procarboxypeptidase U, a novel determinant of the fibrinolytic cascade, in human plasma. | Clin Chem | 1999 Jun |
3 |
| 12 | 10686274 | Proteolytic activation of purified human procarboxypeptidase U. | Clin Chim Acta | 2000 Feb 25 |
1 |
| 13 | 10759708 | Reduced activity of TAFI (thrombin-activatable fibrinolysis inhibitor) in acute promyelocytic leukaemia. | Br J Haematol | 2000 Mar |
2 |
| 14 | 10777524 | Inactivation of active thrombin-activable fibrinolysis inhibitor takes place by a process that involves conformational instability rather than proteolytic cleavage. | J Biol Chem | 2000 Apr 28 |
1 |
| 15 | 10801821 | Elements of the primary structure of thrombomodulin required for efficient thrombin-activable fibrinolysis inhibitor activation. | J Biol Chem | 2000 Jul 28 |
6 |
| 16 | 10831587 | Fluorescence properties and functional roles of tryptophan residues 60d, 96, 148, 207, and 215 of thrombin. | J Biol Chem | 2000 Sep 22 |
1 |
| 17 | 10928462 | Increased fibrinolytic activity during use of oral contraceptives is counteracted by an enhanced factor XI-independent down regulation of fibrinolysis: a randomized cross-over study of two low-dose oral contraceptives. | Thromb Haemost | 2000 Jul |
4 |
| 18 | 11019956 | Plasma procarboxypeptidase U in men with symptomatic coronary artery disease. | Thromb Haemost | 2000 Sep |
1 |
| 19 | 11215380 | [Regulatory mechanism of fibrinolysis system by thrombin activatable fibrinolysis inhibitor (TAFI)]. | Nihon Yakurigaku Zasshi | 2000 Nov |
2 |
| 20 | 11292199 | Carboxypeptidase U at the interface between coagulation and fibrinolysis. | Clin Appl Thromb Hemost | 2001 Apr |
2 |
| 21 | 11463460 | Substrate specificity of recombinant cysteine proteinase, CPB, of Leishmania mexicana. | Mol Biochem Parasitol | 2001 Aug |
5 |
| 22 | 11567668 | Basic principles in thrombolysis: regulatory role of plasminogen. | Thromb Res | 2001 Sep 30 |
2 |
| 23 | 11583330 | Simvastain affects TAFI and thrombomodulin in CAPD patients. | Thromb Haemost | 2001 Sep |
1 |
| 24 | 11684677 | Two naturally occurring variants of TAFI (Thr-325 and Ile-325) differ substantially with respect to thermal stability and antifibrinolytic activity of the enzyme. | J Biol Chem | 2002 Jan 11 |
12 |
| 25 | 11728524 | Patients on peritoneal dialysis but not on hemodialysis have elevated concentration and activity of thrombin-activatable fibrinolysis inhibitor. | Thromb Res | 2001 Nov 15 |
1 |
| 26 | 11802720 | Role of zinc ions in activation and inactivation of thrombin-activatable fibrinolysis inhibitor. | Biochemistry | 2002 Jan 29 |
6 |
| 27 | 11836301 | Insulin resistance is associated with increased circulating level of thrombin-activatable fibrinolysis inhibitor in type 2 diabetic patients. | J Clin Endocrinol Metab | 2002 Feb |
2 |
| 28 | 11871391 | Thr325IIe polymorphism of the TAFI gene does not influence the risk of myocardial infarction. | Blood | 2002 Mar 1 |
1 |
| 29 | 11877267 | Randomized trial of different regimens of heparins and in vivo thrombin generation in acute deep vein thrombosis. | Blood | 2002 Mar 15 |
2 |
| 30 | 11886484 | Oral oestradiol/trimegestone replacement reduces procarboxypeptidase U (TAFI): a randomized, placebo- controlled, 12-week study in early postmenopausal women. | J Intern Med | 2002 Mar |
2 |
| 31 | 11903334 | Association of a single nucleotide polymorphism in CPB2 encoding the thrombin-activable fibrinolysis inhibitor (TAF1) with blood pressure. | Clin Genet | 2001 Nov |
2 |
| 32 | 11939578 | Inactivation of C3a and C5a octapeptides by carboxypeptidase R and carboxypeptidase N. | Microbiol Immunol | 2002 |
3 |
| 33 | 12008932 | Heat stability of carboxypeptidase R of experimental animals. | Microbiol Immunol | 2002 |
4 |
| 34 | 12022872 | Plasmin-mediated activation and inactivation of thrombin-activatable fibrinolysis inhibitor. | Biochemistry | 2002 May 28 |
4 |
| 35 | 12195701 | Effect of heparin on TAFI-dependent inhibition of fibrinolysis: relative importance of TAFIa generated by clot-bound and fluid phase thrombin. | Thromb Haemost | 2002 Aug |
2 |
| 36 | 12478815 | Dyslipidemias and fibrinolysis. | Ital Heart J | 2002 Oct |
1 |
| 37 | 12529754 | Thrombin activatable fibrinolysis inhibitor (TAFI) levels in patients with coronary artery disease investigated by angiography. | Thromb Haemost | 2002 Dec |
1 |
| 38 | 12545342 | Fluvastin therapy affects TAFI concentration in kidney transplant recipients. | Transpl Int | 2003 Jan |
3 |
| 39 | 12842119 | Electrochemiluminescence assay for basic carboxypeptidases: inhibition of basic carboxypeptidases and activation of thrombin-activatable fibrinolysis inhibitor. | Anal Biochem | 2003 Aug 1 |
1 |
| 40 | 12871566 | Rebuttal to: Effect of heparin on TAFI-dependent inhibition of fibrinolysis. | J Thromb Haemost | 2003 Jan |
1 |
| 41 | 12876631 | Association between thrombin-activatable fibrinolysis inhibitor (TAFI) and clinical outcome in patients with unstable angina pectoris. | Thromb Haemost | 2003 Jul |
4 |
| 42 | 12956767 | Thrombin-activatable fibrinolysis inhibitor in young patients with myocardial infarction and its relationship with the fibrinolytic function and the protein C system. | Br J Haematol | 2003 Sep |
1 |
| 43 | 14529894 | Thrombin-activatable fibrinolysis inhibitor in kidney transplant recipient with dyslipidemia. | Transplant Proc | 2003 Sep |
1 |
| 44 | 14567541 | Characterization of thrombin activatable fibrinolysis inhibitor in normal and acquired haemostatic dysfunction. | Blood Coagul Fibrinolysis | 2003 Jun |
2 |
| 45 | 14600375 | Computer-aided modeling of pentachlorophenol 4-monooxygenase and site-directed mutagenesis of its active site. | Chem Pharm Bull (Tokyo) | 2003 Nov |
2 |
| 46 | 14640538 | Synthesis and evaluation of imidazole acetic acid inhibitors of activated thrombin-activatable fibrinolysis inhibitor as novel antithrombotics. | J Med Chem | 2003 Dec 4 |
1 |
| 47 | 14651335 | Polymorphisms in the TAFI gene and the risk of venous thrombosis. | Clin Lab | 2003 |
1 |
| 48 | 14715654 | Activated thrombin-activatable fibrinolysis inhibitor reduces the ability of high molecular weight fibrin degradation products to protect plasmin from antiplasmin. | J Biol Chem | 2004 Apr 2 |
1 |
| 49 | 15099285 | Migration of the activation peptide of thrombin-activatable fibrinolysis inhibitor (TAFI) during SDS-polyacrylamide gel electrophoresis. | J Thromb Haemost | 2004 May |
10 |
| 50 | 15193831 | Effect of atorvastatin on different fibrinolyis mechanisms in hypercholesterolemic subjects. | Int J Cardiol | 2004 Jun |
3 |